On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF stock soared, up nearly 15% at the time of writing on the OTC market.
Here’s what we know.
U-Protein Express Obtains License from Standford, IPATF Stock SoarsU-Protein Express is a wholly-owned subsidiary of ImmunoPrecise Antibodies (TSXV:IPA) (OTCQB:IPATF), which is a therapeutic antibody discovery company based in Victoria, British Columbia, Canada. Today, the subsidiary said Standford University has granted ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.